Treatment of Proctitis
For ulcerative proctitis, start with rectal 5-ASA suppositories 1 g daily as first-line therapy; for sexually transmitted proctitis, use ceftriaxone 125 mg IM plus doxycycline 100 mg twice daily for 7 days. The treatment approach fundamentally depends on whether you're dealing with inflammatory bowel disease-related proctitis or infectious/sexually transmitted proctitis.
Ulcerative Proctitis (IBD-Related)
First-Line Treatment
- Rectal 5-ASA suppository 1 g once daily (typically at night) 1
- This is a strong recommendation based on high-quality evidence showing superiority over placebo with pooled odds ratios of 8.30 for symptomatic remission and 5.31 for endoscopic remission 1
- Rectal 5-ASA is also superior to rectal corticosteroids for inducing remission (OR 1.65) 1
If Incomplete Response After 4-8 Weeks
Add oral 5-ASA 2-3 g daily to the rectal suppository 1, 2
- Evaluate response within 4-8 weeks 1
- The combination of rectal and oral therapy is more effective than oral alone for disease beyond proctitis 1
Second-Line Options for Refractory Disease
If still no response:
- Switch to or add corticosteroid suppository (e.g., prednisolone 5 mg) while continuing oral 5-ASA optimized to 4-4.8 g daily 2
- If this fails: Oral prednisolone 40 mg once daily, weaning over 6-8 weeks 2, 1
Third-Line for Truly Refractory Proctitis
When conventional therapy fails (approximately 30% of patients develop refractory disease 3):
- Anti-TNF therapy (infliximab, adalimumab, or golimumab) 4, 5
- Topical tacrolimus 4, 5
- Anti-integrin therapy (vedolizumab) - recent real-world data shows this may have the highest treatment persistence and response rates in isolated proctitis 6
- JAK inhibitors or S1P agonists 7
Important caveat: Nearly 30% of patients with ulcerative proctitis will develop refractory disease, and approximately 51% may experience proximal disease extension 3, 8. Monitor closely with endoscopy at 3-6 months after treatment initiation 9.
Maintenance Therapy
Once remission is achieved, continue the same therapy that induced remission 1
- For 5-ASA-induced remission: continue rectal 5-ASA suppository daily (can reduce to every 2nd or 3rd day for adherence) 2
- Never use corticosteroids for maintenance - they are ineffective and associated with significant adverse effects 1
Sexually Transmitted/Infectious Proctitis
When to Suspect
Proctitis occurring in patients with recent receptive anal intercourse, presenting with anorectal pain, tenesmus, and rectal discharge 10, 11
Diagnostic Approach
- Perform anoscopy immediately 10
- Evaluate for: N. gonorrhoeae, C. trachomatis (including LGV serovars), T. pallidum, and HSV 10, 11
- Gram stain of anorectal secretions looking for polymorphonuclear leukocytes 10
Empiric Treatment (if anorectal pus or PMNs present)
Ceftriaxone 125 mg IM (or another agent effective against anal/genital gonorrhea) PLUS Doxycycline 100 mg orally twice daily for 7 days 10, 11
This covers both gonorrhea and chlamydia empirically while awaiting culture results.
Special Considerations
- For herpes proctitis: Treat according to genital HSV protocols (this may be especially severe in HIV-coinfected patients) 10, 11
- Proctocolitis (extending >12 cm with diarrhea/cramping): Consider Campylobacter, Shigella, Entamoeba histolytica, or LGV serovars of C. trachomatis 10
- HIV-infected patients: CMV or other opportunistic infections may be involved 10
Critical Differentials to Exclude
Before committing to any treatment, rule out:
- Infection (including sexually transmitted diseases)
- Proximal constipation (can affect drug delivery in distal colitis)
- Crohn's disease
- Rectal prolapse/solitary rectal ulcer syndrome
- Coexistent irritable bowel syndrome
- Malignancy 2
Common pitfall: Poor adherence to rectal therapy is extremely common (5-ASA suppository monotherapy shows the worst compliance at 40% 8). Always assess adherence before escalating therapy. If adherence is an issue, consider switching formulations or reducing frequency rather than immediately escalating to systemic therapy.